Thursday, June 11, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1194 of 1,261
  1. US 6462042

    Hydroxamic acid derivatives as matrix metalloproteinase (mmp) inhibitors

    Darwin Discovery Limited Β· Granted Oct 8, 2002 Β· Expires Oct 3, 2022

    expired
  2. US 6462192

    Processes for large scale production of tetrapyrroles

    Miravant Pharmaceuticals, Inc. Β· Granted Oct 8, 2002 Β· Expires Oct 3, 2022

    expired
  3. US 6462170

    UPAR mimicking peptide

    FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR Β· Granted Oct 8, 2002 Β· Expires Oct 3, 2022

    expired
  4. US 6462067

    Treatment and prevention of reactive oxygen metabolite-mediated cellular damage

    Maxim Pharmaceuticals, Inc. Β· Granted Oct 8, 2002 Β· Expires Oct 3, 2022

    expired
  5. US 6461613

    Methods and compositions for the selective regulation of chorionic prostanoids

    The Board of Regents of the University of Texas System Β· Granted Oct 8, 2002 Β· Expires Oct 3, 2022

    expired
  6. US 6461870

    13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control

    Isotechnika, Inc. Β· Granted Oct 8, 2002 Β· Expires Oct 3, 2022

    expired
  7. US 6462222

    Aminoindan derivatives

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Oct 8, 2002 Β· Expires Oct 3, 2022

    expired
  8. US 6458590

    Methods and compositions for treatment of restenosis

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Oct 1, 2002 Β· Expires Sep 26, 2022

    expired
  9. US 6458782

    Remedies for diabetes

    Institute of Medicinal Molecular Design, Inc. Β· Granted Oct 1, 2002 Β· Expires Sep 26, 2022

    expired
  10. US 6459003

    Ether compounds

    Esperion Therapeutics, Inc. Β· Granted Oct 1, 2002 Β· Expires Sep 26, 2022

    expired
  11. US 6458937

    Glycoconjugates and methods

    The Regents of the University of California Β· Granted Oct 1, 2002 Β· Expires Sep 26, 2022

    expired
  12. US 6458766

    Halovir, an antiviral marine natural product, and derivatives thereof

    The Regents of the University of California Β· Granted Oct 1, 2002 Β· Expires Sep 26, 2022

    expired
  13. US 6458799

    Deazaguanine analog, preparation thereof and use thereof

    BioCryst Pharmaceuticals, Inc. Β· Granted Oct 1, 2002 Β· Expires Sep 26, 2022

    expired
  14. US 6455513

    Chemical compounds

    University College Cardiff Consultants Limited Β· Granted Sep 24, 2002 Β· Expires Sep 19, 2022

    expired
  15. US 6455509

    Dengue nucleic acid vaccines that induce neutralizing antibodies

    United States of America as represented by the Secretary of the Air Force Β· Granted Sep 24, 2002 Β· Expires Sep 19, 2022

    expired
  16. US 6455493

    Methods for using heat shock proteins

    The Regents of the University of New Mexico Β· Granted Sep 24, 2002 Β· Expires Sep 19, 2022

    expired
  17. US 6455669

    Glycopeptide derivatives and pharmaceutical compositions containing the same

    Theravance, Inc. Β· Granted Sep 24, 2002 Β· Expires Sep 19, 2022

    expired
  18. US 6455063

    Propionibacterium P-63 for use in direct fed microbials for animal feeds

    The Board of Regents for Oklahoma State University Β· Granted Sep 24, 2002 Β· Expires Sep 19, 2022

    expired
  19. US 6455038

    Reovirus for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. Β· Granted Sep 24, 2002 Β· Expires Sep 19, 2022

    expired
  20. US 6455035

    Angiopoietins and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. Β· Granted Sep 24, 2002 Β· Expires Sep 19, 2022

    expired
  21. US 6455027

    Methods and kits for identifying ductal orifices in a nipple

    The Regents of the University of California Β· Granted Sep 24, 2002 Β· Expires Sep 19, 2022

    expired
  22. US 6455541

    Suppression, by 5-lipoxygenase inhibitors, of bone resorption

    The Board of Regents of the University of Texas System Β· Granted Sep 24, 2002 Β· Expires Sep 19, 2022

    expired
  23. US 6455589

    Primary N-hydroxylamines

    The Regents of the University of California Β· Granted Sep 24, 2002 Β· Expires Sep 19, 2022

    expired
  24. US 6455531

    Hydroxamic acid derivatives

    Darwin Discovery Limited Β· Granted Sep 24, 2002 Β· Expires Sep 19, 2022

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.